Similarly, BRCA1/2 germline variants are prevalent among these subtypes; however, in our study populations, BRCA1/2 carriers were more common among those with an additional ovarian cancer whereas NCBP1 carriers more frequently had an additional cervical cancer. Here, BRCA1 is linked to ovarian carcinoma.